Clinical Trials Directory

Trials / Completed

CompletedNCT00237042

Managing Temporomandibular Disorder (TMD) Symptoms

Hormonal Cycles in Women: Effects on TMD Pain & Symptoms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
252 (actual)
Sponsor
University of Washington · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether treatments targeted to the hormonal factors and the cyclicity of TMD symptoms associated with the menstrual cycle are more effective in relieving TMD pain and symptoms than standard self management treatment.

Detailed description

Temporomandibular disorders (TMD) are a group of painful conditions involving the muscles of mastication and the temporomandibular joint. These pain problems are about twice as common in women as in men in the community, and prevalence peaks during the reproductive years. The etiology of TMD pain is unknown, but psychological stress, depression and the presence of other somatic complaints have been shown to influence the course of these disorders. Prior research suggests that female reproductive hormones may also influence TMD pain. Specifically, normally cycling women with TMD experience rising levels of TMD pain pre-menstrually during a time of precipitous drop in estrogen and show peak TMD pain during menses. Interestingly, a secondary peak of TMD pain occurs at about the time of ovulation, another phase corresponding to rapid estrogen change. These data demonstrate a systematic relationship between levels of TMD pain and phases of the menstrual cycle. The proposed clinical trial will manipulate the behavioral and hormonal factors that are hypothesized to influence TMD pain, comparing the effects of: * a continuous oral contraceptive intervention designed to suppress menses and stabilize the hormonal environment; * a self-management intervention focused on and timed to the chronobiology of TMD symptoms across the menstrual cycle; and * a usual self-management intervention not timed to biological events. The aims of this clinical trial are to shed light on the mechanisms underlying the cyclic nature of TMD pain and symptoms in women, as well as to determine which treatment modality results in the greatest improvement in TMD pain and symptoms.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSelf ManagementTwo 1.5-hour in-person sessions and 6 10-15-minute telephone calls delivered by a dental hygienist, trained and supervised by a clinical psychologist. Structured, manual-based treatment based on standard cognitive-behavioral pain therapies and self-management interventions for chronic TMD pain. Sessions included education about the biopsychosocial model of chronic pain, TMD etiology and treatments, and the rationale for self-management; relaxation and stress management training; discussion of the role of stress and emotions as potential factors exacerbating and maintaining TMD symptoms; instruction and practice in self-monitoring of symptoms to identify factors that might be helpful to modify through self-care methods; practice of dentist-prescribed self-care treatments; and discussion of strategies to maintain gains and prevent relapse.
BEHAVIORALTargeted Self ManagementSelf management as described above. However, the intervention also included education about the potential effects of hormones on TMD pain, instructions to monitor the association of pain and other symptoms with menstrual cycle changes, and planning for times in participants' menstrual cycles when symptoms might increase. Participant contacts were timed according to each participant's menstrual cycle.
DRUG20 mcg ethinyl estradiol and 100 mcg levonorgestrelCombination pill (20 mcg ethinyl estradiol and 100 mcg levonorgestrel) taken daily for 6 months.

Timeline

Start date
2005-10-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2005-10-12
Last updated
2011-07-11
Results posted
2011-07-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00237042. Inclusion in this directory is not an endorsement.